Treatment and diagnosis of dementia

Details Treatment and diagnosis of dementia Treatment and diagnosis of dementia

1988-01-26

1990-07-03

Stone, Jacqueline

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514879, 436 63, 436811, A61K 3736, G01N 3374

Patent

active

049391240

ABSTRACT:
The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders.
Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.

REFERENCES:
patent: 4622312 (1986-11-01), Felix et al.
patent: 4727041 (1988-02-01), Aroonsakul
patent: 4728638 (1988-03-01), Bauer et al.
patent: 4791099 (1988-12-01), Aroonsakul
Reubi et al., Cited in Chem. Abstracts, vol. 102: 191161k (1985).
GHRH-Induced GH Response in Patients with Senile Dementia of the Alzheimer Type, Ramon Cacabelos, Acta Endocrinologica (Copenh) 1988, 117: 295-301.

Affiliated with

Also associated with

Rating

Treatment and diagnosis of dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment and diagnosis of dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and diagnosis of dementia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1890848